journal article·2017-02-17Open access

Development of an effective delivery system for intranasal immunization against Mycobacterium tuberculosis ESAT-6 antigen

Yousef Amini, Majid Tebianian, Nader Mosavari, Mahdi Fasihi Ramandi, Seyyd Mahmoud Ebrahimi, Hamid Najminejad, Mehran Dabaghian, Meghdad Abdollahpour

Abstract

Introduction The early secreted antigenic target 6-kDa protein (ESAT-6) plays an important role in immune protection against Tuberculosis. Owing to its great potential to increase immune response, chitosan can be considered as a suitable biodegradable polymer for intranasal administration. Methods The physiochemical properties of the nanoparticle were measured in vitro. Two weeks after the last intranasal administration, blood samples were collected and specific IgG, IFN-gama, and IL-4 levels were measured by ELISA. Results Chitosan nanoparticles containing ESAT-6 demonstrated stronger ability to induce IFN-gama, IL-4, and IgG antibody level than the control groups. Conclusion Administration of chitosan nanoparticles can be a suitable method to induce more appropriate immune responses against low inherent immunogenic tuberculosis proteins through intranasal routs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Pneumonia and Respiratory Infections · Immune Response and Inflammation · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Microbiology & Virology Research Center, Bu-Ali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran;

Razi Vaccine and Serum Institute, Karaj, Iran;

Molecular Biology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran;

Baqiyatallah University of Medical Sciences, Tehran, Iran;

Shahid Sadoughi University of Medical Science, Yazd, Iran;

Department of Immunology, Pasteur Institute of Iran, Tehran, Iran

References (41)

Show source-provided references
1. 10.1016/j.addr.2009.11.00910.1016/j.addr.2009.11.009 ↗
2. 10.1016/S1471-4906(01)01865-810.1016/S1471-4906(01)01865-8 ↗
3. 10.1084/jem.142.1.110.1084/jem.142.1.1 ↗
4. 10.1016/S0264-410X(98)00419-810.1016/S0264-410X(98)00419-8 ↗
5. 10.4049/jimmunol.100318910.4049/jimmunol.1003189 ↗
6. 10.1586/erv.09.16010.1586/erv.09.160 ↗
7. 10.1128/IAI.68.2.791-795.200010.1128/IAI.68.2.791-795.2000 ↗
8. 10.1007/BF0242149210.1007/BF02421492 ↗
9. 10.1016/j.jconrel.2005.01.01410.1016/j.jconrel.2005.01.014 ↗
10. 10.1016/j.molimm.2009.11.00510.1016/j.molimm.2009.11.005 ↗
11. 10.1016/S0140-6736(95)92348-910.1016/S0140-6736(95)92348-9 ↗
12. 10.1164/rccm.200504-613PP10.1164/rccm.200504-613PP ↗
13. 10.1002/jmv.2141510.1002/jmv.21415 ↗
14. 10.1016/S0264-410X(02)00435-810.1016/S0264-410X(02)00435-8 ↗
15. Harboe M · Infect Immun. · 1996 · 64 · 1610.1128/IAI.64.1.16-22.1996 ↗
16. Henson D · 971). J Immunol. · 2014 · 192 · 141
17. 10.1023/B:PHAM.0000016249.52831.a510.1023/B:PHAM.0000016249.52831.a5 ↗
18. 10.1016/S0169-409X(01)00171-510.1016/S0169-409X(01)00171-5 ↗
19. 10.3109/1061186X.2010.52379010.3109/1061186X.2010.523790 ↗
20. 10.4161/hv.2613610.4161/hv.26136 ↗
21. 10.1016/S0171-2985(11)80437-710.1016/S0171-2985(11)80437-7 ↗
22. 10.1038/ni0504-46010.1038/ni0504-460 ↗
23. 10.1038/cmi.2009.610.1038/cmi.2009.6 ↗
24. 10.1128/JB.178.5.1274-1282.199610.1128/JB.178.5.1274-1282.1996 ↗
25. 10.1016/j.vaccine.2003.09.01210.1016/j.vaccine.2003.09.012 ↗
26. 10.1023/B:PHAM.0000022414.17183.5810.1023/B:PHAM.0000022414.17183.58 ↗
27. 10.1189/jlb.090454110.1189/jlb.0904541 ↗
28. 10.1016/j.vetimm.2009.10.02810.1016/j.vetimm.2009.10.028 ↗
29. 10.1086/31464010.1086/314640 ↗
30. 10.1016/j.it.2006.10.00510.1016/j.it.2006.10.005 ↗
31. Shaji J · Int J Pharm Appl Sci. · 2010 · 1 · 11
32. 10.1038/nrmicro141910.1038/nrmicro1419 ↗
33. 10.1016/j.vaccine.2010.06.12110.1016/j.vaccine.2010.06.121 ↗
34. 10.1016/j.jconrel.2009.05.01110.1016/j.jconrel.2009.05.011 ↗
35. 10.1007/s00253-015-6952-z10.1007/s00253-015-6952-z ↗
36. 10.1046/j.1365-2222.2002.01551.x10.1046/j.1365-2222.2002.01551.x ↗
37. 10.1016/j.biologicals.2011.02.00210.1016/j.biologicals.2011.02.002 ↗
38. 10.1016/j.ejpb.2003.09.00610.1016/j.ejpb.2003.09.006 ↗
39. Wang L · Chinese Med J. · 2007 · 120 · 122010.1097/00029330-200707020-00003 ↗
40. 10.1093/bmb/62.1.7310.1093/bmb/62.1.73 ↗
41. 10.1155/2012/19392310.1155/2012/193923 ↗